Aylin Yucel, PhD, MSc, MBA, MHSA, PharmD

Articles by Aylin Yucel, PhD, MSc, MBA, MHSA, PharmD

The Long-term Social Value of Granulocyte Colony-Stimulating Factors

ByAlison Sexton Ward, PhD,Mina Kabiri, PhD,Aylin Yucel, PhD, MSc, MBA, MHSA, PharmD,Alison R. Silverstein, MPH,Emma van Eijndhoven, MS, MA,Charles Bowers, MD,Mark Bensink, PhD, MSc, MEd,Dana Goldman, PhD

October 4th 2019

Although currently underutilized, granulocyte colony-stimulating factor prophylaxis as supportive cancer care provides substantial value to society. Aligning utilization with clinical guidelines would increase this value considerably.

Latest Updated Articles

The Long-term Social Value of Granulocyte Colony-Stimulating Factors
October 4th 2019

Aylin Yucel, PhD, MSc, MBA, MHSA, PharmD

Articles by Aylin Yucel, PhD, MSc, MBA, MHSA, PharmD

The Long-term Social Value of Granulocyte Colony-Stimulating Factors

Latest Updated Articles

Trending on AJMC

FDA Panel Backs 6 Peptides for Compounding

FAQs: Cyclospora Recovery, Treatment, and Outbreak Prevention Strategies

Study Shows Potential for Low-Dose CAR T, With Implications for Increased Access

Teclistamab-Talquetamab Combo Cuts Myeloma Progression Risk by 89%